Inhibition of vasoconstriction by angiotensin receptor antagonist GR117289C in arterial grafts

Annals of Thoracic Surgery

Volumn 70, Issue 6, 2000, Pages 2064-2069

  Liu, Ming Hui ^a,b   Floten, H Storm ^a,b   Furnary, Anthony P ^a,b   Yim, Anthony P C ^a,b   He, Guo Wei ^a,b  

^a PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ENDOTHELIN 1; NORADRENALIN; POTASSIUM CHLORIDE; VASOCONSTRICTOR AGENT; ZOLASARTAN;

ADULT; AGED; ARTERY GRAFT; ARTERY SPASM; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG MECHANISM; DRUG SELECTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

AGED; ANGIOTENSIN II; CORONARY ARTERY BYPASS; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MALE; MAMMARY ARTERIES; MIDDLE AGED; NICOTINIC ACIDS; RECEPTORS, ANGIOTENSIN; TETRAZOLES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0034528198     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01935-4     Document Type: Article

References (23)

1. The renin angiotensin system
2. Nomenclature for angiotensin receptors: A report of the nomenclature committee of the Council for High Blood Pressure Research
3. Angiotensin-induced cyclic GMP production is mediated by multiple receptor subtypes and nitric oxide in N1E-115 neuroblastoma cells
4. Angiotensin type 1 receptors mediate depressor phase of biphasic pressure response to angiotensin
5. Angiotensin II receptor subtypes: Characterization, signaling mechanisms, and possible physiological implications
6. Angiotensin converting enzyme inhibitors: Properties and side effects
7. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy
8. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II
9. Bromobenzofurans. A new class of potent, non-peptide antagonists of angiotensin II
10. Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm
11. Peripheral vascular resistance and angiotensin II levels during pulsatile cardiopulmonary bypass
12. Factors relating to the development of hypertension after cardiopulmonary bypass
13. Influence of endothelium and surgical preparation on responses of human saphenous vein and internal thoracic artery to angiotensin II
14. Comparison of nitroprusside and nitroglycerin in inhibition of angiotensin II and other vasoconstrictor-mediated contraction in human coronary bypass conduits
15. Reactivity of human isolated internal mammary artery to constrictor and dilator agents: Implications for treatment of internal mammary artery spasm
16. 2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery
17. Interaction between endothelin and vasodilators in the human internal mammary artery
18. Different effects of activated platelets in the right gastroepiploic and internal mammary arteries: Implications for coronary artery grafting
19. Overview of the nature of vasoconstriction in arterial grafts for coronary operations
20. 1 receptor antagonist
21. 2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog
22. 1 receptor antagonist
23. 2-induced contractions in canine coronary arteries